Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors
Clinical trial NCT06346041 · RECRUITING
Trial details
- NCT number
- NCT06346041
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-12
- Primary completion
- 2025-12-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.